Technology transfer, pharmaceutical development for solid dosage forms (tablet, granulates, a.o.) for clinical studies, liquids and creams. Study development and monitoring (Phase I-II), CRO biomarker development for inflammatory and autoimmun diseases, product management for pharmacies, licensing and marketing
R&D:bioactive substances and metabolism formulation of APIs qualification and standardisation of bioactive substances Biomarker development for inflammatory diagnostics solid dose formulation development for synthetic and natural active ingredients, process development for natural and synthetic active ingredients,
Production:Clinical Trial Products for studies (off label use)
Services:Programm management for technology transfer, contracting and licensing of products product life cycle management product launch management clinical study design observational studies
Sales/Distribution:samples for clinical trials (dermatologics) and observational studies